An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
buyback
Rhea-AI Summary
Cencora, Inc. (NYSE: COR) announces agreement to repurchase $250 million worth of common stock from Walgreens Boots Alliance Holdings LLC in concurrence with Rule 144 transactions.
Positive
None.
Negative
None.
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--
Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $250 million in concurrence with Walgreens Boots Alliance’s entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended.
Cencora intends to repurchase shares from Walgreens Boots Alliance at the per share price equal to the price in the Rule 144 transaction. The concurrent share repurchase will be made under Cencora’s share repurchase program and the repurchased shares will be held in treasury.
About Cencora
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $250 billion in annual revenue. Learn more at www.investor.cencora.com
Bennett S. Murphy
Senior Vice President, Head of Investor Relations & Treasury
610-727-3693
Bennett.Murphy@cencora.com
Source: Cencora
FAQ
What is the latest announcement from Cencora, Inc. (NYSE: COR)?
Cencora, Inc. (NYSE: COR) has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $250 million.
What is the purpose of the share repurchase program?
The purpose is to repurchase shares from Walgreens Boots Alliance at the per share price equal to the price in the Rule 144 transaction and the repurchased shares will be held in treasury.
What is the significance of the concurrent share repurchase?
The concurrent share repurchase is made under Cencora’s share repurchase program and is part of Walgreens Boots Alliance’s entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
